TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
KRYS

Krystal Biotech Inc

Healthcare · Biotechnology

345.80$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Krystal Biotech Inc (KRYS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,501 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KRYS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
790 818 853 918 982 1,056 1,074 1,138 1,240 1,334 1,397 1,501
582 588 602 683 713 742 767 841 926 1,025 1,020 1,060
373 358 359 346 374 345 309 354 393 496 501 428
562 532 538 560 588 598 617 682 731 828 823 846
9.3 42 46 103 97 105 103 111 130 127 127 139
5.3 7.0 11 12 19 27 30 31 38 40 43 46
34 40 54 79 96 109 90 98 102 114 120 142
28 33 48 72 90 102 79 87 91 103 108 127
1.5 1.5 1.4 1.4 1.3 1.2 1.4 1.6 1.7 1.8 1.8 1.8
4.3 4.1 5.4 5.4 5.6 5.0 2.7 7.1 2.1 3.2 4.1 6.5
756 779 799 839 886 946 985 1,041 1,138 1,220 1,277 1,359
-279 -270 -269 -253 -226 -181 -145 -107 -27 24 80 135
29 29 29 30 30 30 30 30 30 30 31 31

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?